Close
Help





JOURNAL

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine

Pharmacotherapies for COPD

Submit a Paper


Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 2013:7 17-34

Review

Published on 25 Apr 2013

DOI: 10.4137/CCRPM.S7211


Further metadata provided in PDF



Sign up for Email Alerts and keep in touch with Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine journal news, updates, events and articles

Abstract

This review article summarizes the main treatments for chronic obstructive pulmonary disease, their mechanisms, and the key evidence from trials supporting their use. Drug classes covered were short acting beta agonists (SABA), short acting muscarinic antagonists (SAMA), long acting beta agonists (LABA), long acting antimuscarinics (LAMA), inhaled corticosteroids (ICS), LABA/ICS combinations, specific phosphodiesterase (PDE4) inhibitors, non-specific PDE inhibitors, mucolytics, and oxygen. Non-specific therapies, such as opiates for relief of dyspnoea and therapies for smoking cessation, are also covered briefly. For each class of drug, mechanisms of action are described, key clinical trial results are reported, and available agents compared. Finally, the place of each drug in therapy is compared between current worldwide guidelines.



Downloads

PDF  (700.86 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML




What Your Colleagues Say About Libertas Academica
Publishing in  “Clinical Medicine Insights: Oncology” was one of my best experience so far in an academic context. I found the process of going through submission, review, editing, and publication to be quite easy and most importantly, fair and efficient. I congratulate the team at Libertas Academica for a very well managed journal. 
Dr E.I. Efremidou (Assistant Professor in Surgery, Medical School, Democritus University of Thrace, Hellas)
More Testimonials

Quick Links


New article and journal news notification services